These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12511877)

  • 1. The autoantibody repertoire: searching for order.
    Plotz PH
    Nat Rev Immunol; 2003 Jan; 3(1):73-8. PubMed ID: 12511877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The natural polyspecific autoantibody repertoire of man].
    Jahn S; Roggenbuck D; Settmacher U; Schwab J; Bohn J; Kiessig ST; von Baehr R; Porstmann T
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):479-84. PubMed ID: 7856248
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiplexing approaches for autoantibody profiling in multiple sclerosis.
    Somers K; Govarts C; Stinissen P; Somers V
    Autoimmun Rev; 2009 Jun; 8(7):573-9. PubMed ID: 19393211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Class A scavenger receptors regulate tolerance against apoptotic cells, and autoantibodies against these receptors are predictive of systemic lupus.
    Wermeling F; Chen Y; Pikkarainen T; Scheynius A; Winqvist O; Izui S; Ravetch JV; Tryggvason K; Karlsson MC
    J Exp Med; 2007 Oct; 204(10):2259-65. PubMed ID: 17893199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential use of immunoblots for characterization of autoantibody specificities.
    Bartsch H; Bachmann M
    Methods Mol Biol; 2009; 536():293-8. PubMed ID: 19378068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: Inflammation in their induction and impact on tumor growth.
    Bei R; Masuelli L; Palumbo C; Modesti M; Modesti A
    Cancer Lett; 2009 Aug; 281(1):8-23. PubMed ID: 19091462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptotic modifications affect the autoreactivity of the U1 snRNP autoantigen.
    Hof D; Raats JM; Pruijn GJ
    Autoimmun Rev; 2005 Jul; 4(6):380-8. PubMed ID: 16081029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiling humoral autoimmune repertoire of dilated cardiomyopathy (DCM) patients and development of a disease-associated protein chip.
    Horn S; Lueking A; Murphy D; Staudt A; Gutjahr C; Schulte K; König A; Landsberger M; Lehrach H; Felix SB; Cahill DJ
    Proteomics; 2006 Jan; 6(2):605-13. PubMed ID: 16419013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating immunity: the immunculus and self-reactivity.
    Poletaev AB; Stepanyuk VL; Gershwin ME
    J Autoimmun; 2008; 30(1-2):68-73. PubMed ID: 18191542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered structure of autoantigens during apoptosis.
    Hall JC; Casciola-Rosen L; Rosen A
    Rheum Dis Clin North Am; 2004 Aug; 30(3):455-71, vii. PubMed ID: 15261336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When autologous chromatin becomes a foe.
    Muñoz LE; Herrmann M
    Autoimmunity; 2012 Dec; 45(8):565-7. PubMed ID: 22978407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis of the autoantibody response following immunization with a single autoantigen.
    Mouquet H; Drouot L; Charlionnet R; Arnoult C; Bonnet-Bayeux F; Thomas M; Leprince J; Joly P; Tron F; Gilbert D
    Proteomics; 2006 Sep; 6(17):4829-37. PubMed ID: 16892487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mature dendritic cells readily break tolerance in normal mice but do not lead to disease expression.
    Georgiev M; Agle LM; Chu JL; Elkon KB; Ashany D
    Arthritis Rheum; 2005 Jan; 52(1):225-38. PubMed ID: 15641101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of immunologic tolerance in dermatology].
    Steinbrink K; Knop J
    Hautarzt; 2003 Jan; 54(1):45-52. PubMed ID: 12567257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mimicry in innate immunity? The viral RNA recognition receptor TLR7 accelerates murine lupus.
    Anders HJ; Krug A; Pawar RD
    Eur J Immunol; 2008 Jul; 38(7):1795-9. PubMed ID: 18581336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
    Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of self-antigen-specific CD4+ CD25+ regulatory T cells selected in vitro from a polyclonal repertoire.
    Fisson S; Djelti F; Trenado A; Billiard F; Liblau R; Klatzmann D; Cohen JL; Salomon BL
    Eur J Immunol; 2006 Apr; 36(4):817-27. PubMed ID: 16525991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defects in the regulation of B cell apoptosis are required for the production of citrullinated peptide autoantibodies in mice.
    López-Hoyos M; Marquina R; Tamayo E; González-Rojas J; Izui S; Merino R; Merino J
    Arthritis Rheum; 2003 Aug; 48(8):2353-61. PubMed ID: 12905491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerization of an established alphaB-crystallin-reactive T-cell response by intravenous antigen.
    Verbeek R; van der Mark K; Wawrousek EF; Plomp AC; van Noort JM
    Immunology; 2007 Jul; 121(3):416-26. PubMed ID: 17386078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantigens act as tissue-specific chemoattractants.
    Oppenheim JJ; Dong HF; Plotz P; Caspi RR; Dykstra M; Pierce S; Martin R; Carlos C; Finn O; Koul O; Howard OM
    J Leukoc Biol; 2005 Jun; 77(6):854-61. PubMed ID: 15917448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.